← Back to Search

Project ALERT + Getting To Outcomes for Substance Abuse (GTO-ALERT Trial)

N/A
Recruiting
Led By Eric Pedersen, PhD
Research Sponsored by RAND
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes assessed for past year perceived peer use at each follow-up point from baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how well Project ALERT works when used with the support enhancement tool, Getting To Outcomes.

Who is the study for?
This trial is for 7th-grade students, mostly aged 12-14, who are attending one of the schools participating in the study. School staff at these schools interested in joining the study can also participate.
What is being tested?
The trial is evaluating Project ALERT, a substance abuse prevention program, with an added tool called Getting To Outcomes to enhance its effectiveness in middle schools.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there aren't typical side effects like you'd see with medication. However, participants may experience stress or discomfort during discussions about substance use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes assessed for past year use at each follow-up point from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes assessed for past year use at each follow-up point from baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Student alcohol and drug behavior
Student pro-substance use risk factors on consequences
Student pro-substance use risk factors on expectancies
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Project ALERT onlyActive Control1 Intervention
Some schools will be randomized to receive Project ALERT only for 3 years starting fall 2022.
Group II: Project ALERT plus GTOActive Control2 Interventions
Some schools will be randomized to receive Project ALERT plus Getting to Outcomes for 3 years starting fall 2022.
Group III: Status quoActive Control1 Intervention
Some schools not receive either Project ALERT or Project ALERT plus GTO until year 3 of the study.

Find a Location

Who is running the clinical trial?

RANDLead Sponsor
142 Previous Clinical Trials
616,243 Total Patients Enrolled
University of Southern CaliforniaOTHER
946 Previous Clinical Trials
1,604,577 Total Patients Enrolled
Eric Pedersen, PhDPrincipal InvestigatorUniversity of Southern California
Matthew Chinman, PhDPrincipal InvestigatorRAND
3 Previous Clinical Trials
2,326 Total Patients Enrolled

Media Library

Project ALERT Clinical Trial Eligibility Overview. Trial Name: NCT05219422 — N/A
Addiction Research Study Groups: Project ALERT only, Project ALERT plus GTO, Status quo
Addiction Clinical Trial 2023: Project ALERT Highlights & Side Effects. Trial Name: NCT05219422 — N/A
Project ALERT 2023 Treatment Timeline for Medical Study. Trial Name: NCT05219422 — N/A
~2 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top